
Plus Therapeutics Stock Skyrockets After FDA Greenlight for Childhood Brain Cancer Treatment
Buckle up, traders, because today’s market is serving up some serious action, and one stock is stealing the spotlight! Plus Therapeutics, Inc. (Nasdaq: PSTV) is screaming higher, with shares surging as of this writing, thanks to a game-changing …